MedTrace Logo

Estimation of Pentrexin-3 Levels in GCF and Saliva of Patients With Periodontal Disease

NCT03128502 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2017-06-15

No results posted yet for this study

Summary

Subjects were selected from the outpatient clinic, Department of Oral Medicine and Periodontology, Faculty of Oral and Dental Medicine, Cairo University. Ten healthy control subjects presented with clinically healthy periodontium. Ten patients who had plaque induced gingivitis. Ten patients who had generalized chronic periodontitis. Ten patients who had generalised aggressive periodontitis. Pentraxin-3 levels were evaluated in GCF and saliva of all subjects included in this study with ELISA technique.

Conditions

  • Chronic Periodontitis
  • Aggressive Periodontitis

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Engy Ahmed, M.D. · Associate Professor of Oral Medicine & Periodontology, faculty of Oral and Dental Medicine, Cairo University

  • Yasmine Mansour, B.D.Sc · master candidate at faculty of dentistry cairo university

  • Olfat Shaker · Professor of Medical Biochemistry, Faculty of Medicine, Cairo University

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2017-02-28
Completion
2017-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03128502 on ClinicalTrials.gov